Diabetes News and Research

Latest Diabetes News and Research

Janssen submits canagliflozin NDA with FDA for treatment of type 2 diabetes

Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.

1 Jun 2012

Researchers uncover potential new way to regulate the body's natural immune response

Australian researchers have uncovered a potential new way to regulate the body's natural immune response, offering hope of a simple and effective new treatment for auto-immune diseases.

1 Jun 2012

Top-line results from Genzyme’s teriflunomide Phase III trial on MS

Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.

1 Jun 2012

Researchers investigate how iPFK2 enzyme may benefit some obese people

Why is it that some obese people are healthier than others? This was one of the main questions Dr. Chaodong Wu of the College of Agriculture and Life Sciences - Texas A&M University System - and a group of researchers tried to answer in a recent study.

1 Jun 2012

IU scientists successfully transplant primary kidney cells intravenously to treat renal failure

Indiana University School of Medicine scientists have successfully transplanted primary kidney cells intravenously to treat renal failure in rats, pointing the way to a possible future alternative to kidney transplants and expensive dialysis treatments in humans.

1 Jun 2012

Einstein receives NIH grant to create new vaccine against TB

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.

1 Jun 2012

suPAR protein can serve as marker for blood poisoning

Blood poisoning is a serious problem in medical care. Research from Malmö University in Sweden now shows that the protein suPAR, which can be used for early detection of critical cases of sepsis, is found in saliva, which opens new potential for tracking diseases.

1 Jun 2012

FDA approves RBI’s AppliGel-G for human testing

Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers.

1 Jun 2012

Noncommunicable diseases need more attention among prisoners

Prisons are not taking appropriate action to improve diet and increase physical activity levels to help prevent noncommunicable diseases among prisoners, say UK researchers in The Lancet.

31 May 2012

New method can solve 3-D structures of integral membrane proteins

A new method for rapidly solving the three-dimensional structures of a special group of proteins, known as integral membrane proteins, may speed drug discovery by providing scientists with precise targets for new therapies, according to a paper published May 20 in Nature Methods.

31 May 2012

4,600 lives could be saved a year by cutting daily alcohol intake to half a unit (5g)

Cutting daily alcohol intake to just over half a unit (5 g), could save 4,600 lives a year in England, say experts in the online journal BMJ Open.

31 May 2012

TSRI receives $2 million donation from Esther B. O'Keeffe Charitable Foundation

The Esther B. O'Keeffe Charitable Foundation has made a $2 million donation to The Scripps Research Institute to fund biomedical research and education on the Florida campus. In recognition of the gift, the Founders Room and the adjoining board room at Scripps Florida have been named the Esther B. O'Keeffe Founders Suite.

31 May 2012

No evidence of chronic low-grade inflammation linked with diseases of aging

American parents may want to think again about how much they want to protect their children from everyday germs. A new Northwestern University study done in lowland Ecuador remarkably finds no evidence of chronic low-grade inflammation -- associated with diseases of aging like cardiovascular disease, diabetes and dementia.

31 May 2012

U.S. FDA clears INJEX Pharma’s needle free injection system

The FDA had registered INJEX Pharma GmbH, Berlin, and INJEX Pharma US, Miami, and given approval for the import and sale of INJEX 30 in the US market. The condition was the registration by the FDA for INJEX Pharma GmbH as manufacturer and exporter.

31 May 2012

Fever in pregnancy raises autism risk

Children whose mothers experience fever during pregnancy have an increased risk for developing autism compared with other children, show study findings.

30 May 2012

Insulin use linked to lung cancer risk in diabetes

Postmenopausal women with treated diabetes may be at an increased risk for lung cancer, particularly if they are on insulin, say researchers.

30 May 2012

Researchers identify mechanism key in drug allergy

Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy & Immunology could lead to a new way to dramatically improve drug safety by identifying drugs at risk to cause potentially fatal genetic-linked hypersensitivity reactions before their use in man.

30 May 2012

Calcium supplements may raise heart attack risk

Increased dietary calcium intake has no overall cardiovascular benefits, and calcium supplements appear to raise the risk for myocardial infarction, warn investigators.

30 May 2012

Death prediction for patients with pneumonia and raised glucose levels

Raised blood sugar (glucose) levels on admission to hospital can predict deaths in patients with community acquired pneumonia but without pre-existing diabetes, finds a study published on bmj.com today.

30 May 2012

Better urban planning is key to improving health of 60% of global population that will be living in cities by 2030

The proportion of the world’s population that lives in cities has been steadily rising, so that 3 in 5 of all people globally will live in a city by 2030. The UCL (University College London)/Lancet Commission on Healthy Cities explores the many issues other than health services that contribute to population health in a city environment.

30 May 2012